These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6730783)

  • 1. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the therapeutics of experimental toxoplasmosis. II. Effect of acetylspiramycin alone or in combination with an immunopotentiator (CSP-II) or sulfamethopyrazine on Toxoplasma multiplication in the heart of mice acutely and chronically infected with Toxoplasma gondii (author's transl)].
    Espinas FM; Takei Y; Sakurai H; Odakura Y; Suzuki N; Sasaki H
    Jpn J Antibiot; 1982 Feb; 35(2):362-8. PubMed ID: 7087173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasmacidal activity of Obioactin derived from hydrolyzed Toxoplasma immune bovine serum in heterologous cell cultures.
    Suzuki N; Izumo A; Sakurai H; Saito A; Miura H; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):356-66. PubMed ID: 6328796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)].
    Espinas FM; Odakura Y; Suzuki N; Sasaki H
    Jpn J Antibiot; 1981 Aug; 34(8):1141-7. PubMed ID: 7321193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
    Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
    Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
    Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.
    Werner H; Matuschka FR; Brandenburg I
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):240-53. PubMed ID: 44617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ultra-long-acting sulphonamide, sulphamethoxypyrazine (Longum-Kelfizina) on the proliferative phase of replication of Toxoplasma gondii in NMRI mice. Contribution to experimental chemotherapy of toxoplasmosis].
    Werner H; Dannemann R; Egger I
    Zentralbl Bakteriol Orig A; 1972 Oct; 222(1):126-41. PubMed ID: 4145146
    [No Abstract]   [Full Text] [Related]  

  • 11. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
    Chew WK; Segarra I; Ambu S; Mak JW
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1762-8. PubMed ID: 22271863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
    Gormley PD; Pavesio CE; Minnasian D; Lightman S
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1171-5. PubMed ID: 9620076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of Obioactin.
    Osaki H; Furuya M; Nagasawa H; Suzuki N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):328-34. PubMed ID: 6328795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.
    Matuschka FR
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):419-29. PubMed ID: 910581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
    Djurković-Djaković O; Nikolić A; Bobić B; Klun I; Aleksić A
    Microbes Infect; 2005 Jan; 7(1):49-54. PubMed ID: 15716077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii: kinetics of the dissemination in the host tissues during the acute phase of infection of mice and rats.
    Zenner L; Darcy F; Capron A; Cesbron-Delauw MF
    Exp Parasitol; 1998 Sep; 90(1):86-94. PubMed ID: 9709034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies.
    El Zawawy LA
    J Egypt Soc Parasitol; 2008 Apr; 38(1):185-201. PubMed ID: 19143130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X; Ke OY; Zhang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
    Araujo FG; Huskinson J; Remington JS
    Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
    Wei HX; Wei SS; Lindsay DS; Peng HJ
    PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.